Inflammatory Biomarkers for Assessing Treatment Response in Psoriasis: A Narrative Review
Although inflammatory biomarkers provide a biologically grounded framework for assessing treatment response, their clinical implementation remains limited and further large-scale, standardized studies are required to validate candidate markers and support the development of integrated, multi-omics approaches for personalized management.